Canada markets closed

Takeda Pharmaceutical Company Limited (TKPHF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
26.62+0.56 (+2.15%)
At close: 09:49AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 41.68B
Enterprise Value 69.48B
Trailing P/E 36.66
Forward P/E 23.26
PEG Ratio (5 yr expected) 3.26
Price/Sales (ttm)1.56
Price/Book (mrq)0.96
Enterprise Value/Revenue 0.02
Enterprise Value/EBITDA 0.07

Trading Information

Stock Price History

Beta (5Y Monthly) 0.54
52-Week Change 3-19.48%
S&P500 52-Week Change 323.57%
52 Week High 334.47
52 Week Low 325.04
50-Day Moving Average 327.70
200-Day Moving Average 328.87

Share Statistics

Avg Vol (3 month) 36.1k
Avg Vol (10 day) 3420
Shares Outstanding 51.57B
Implied Shares Outstanding 61.6B
Float 81.55B
% Held by Insiders 10.03%
% Held by Institutions 144.73%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 41.24
Forward Annual Dividend Yield 44.77%
Trailing Annual Dividend Rate 3184.00
Trailing Annual Dividend Yield 3706.20%
5 Year Average Dividend Yield 44.58
Payout Ratio 4163.61%
Dividend Date 3Jun 28, 2010
Ex-Dividend Date 4Mar 28, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 4.28%
Operating Margin (ttm)9.44%

Management Effectiveness

Return on Assets (ttm)2.61%
Return on Equity (ttm)2.76%

Income Statement

Revenue (ttm)4.17T
Revenue Per Share (ttm)2,670.94
Quarterly Revenue Growth (yoy)1.30%
Gross Profit (ttm)N/A
EBITDA 1.21T
Net Income Avi to Common (ttm)178.22B
Diluted EPS (ttm)0.71
Quarterly Earnings Growth (yoy)-11.30%

Balance Sheet

Total Cash (mrq)288.36B
Total Cash Per Share (mrq)183.79
Total Debt (mrq)5.21T
Total Debt/Equity (mrq)77.21%
Current Ratio (mrq)1.06
Book Value Per Share (mrq)4,297.21

Cash Flow Statement

Operating Cash Flow (ttm)731.45B
Levered Free Cash Flow (ttm)-9.88B